MAPT and Alzheimer disease: We found that both 3R- and 4R-tau151-391 were captured from the corresponding cell lysates dose-dependently by brain extracts of AD and PiD3, but not from those tissue samples that did not contain hyperphosphorylated and HMW-tau species, including control and one AD and seven tauopathy cases (Fig. 3a–c).